Neurofibromatosis, type 1 (disorder)

Neurofibromatosis Type 1 Collection

Year Started: 1990



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Unknown

Data not recorded

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) -60°C to -85°C N/A Not applicable 51 - 75%
Tissue specimen Surgical procedure (procedure) RT Paraffin Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 16 Clinical Trial Collection

Year Started: 2006

Samples from the AML 16 trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%


Male

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%

Acute myeloid leukemia, disease (disorder)

AML 17 Clinical Trial Collection

Year Started: 2007

Samples from the AML 17 trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%

Chronic obstructive lung disease (disorder)

PACE

Year Started: 2014

A clinical trial to explore GP use of a C-Reactive Protein Point of Care Test to help target antibiotic prescribing to patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) who are most likely to benefit.



Access:
Open to applicants
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Sputum -60°C to -85°C Not applicable 51 - 75%
Swab -60°C to -85°C Not applicable 75% -99%


Male

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Sputum -60°C to -85°C Not applicable 75% -99%
Swab -60°C to -85°C Not applicable 75% -99%